Bpifrance, a public sector investment bank, and Pemberton, a debt manager investing in non-investment grade debt, completed the investment in Juvisé Pharmaceuticals, a pharmaceutical company, specialized in manufacturing and marketing ethical brands. Financial terms were not disclosed.